2007 Annual Meeting | Critical Care of Brain Hemorrhage
| 09:00 AM - 09:40 AM | Blood Pressure Mangement Michael N. Diringer, MD | |
| 09:40 AM - 10:20 AM | Management of the Anticoagulated Patient Venkatesh Aiyagari, MD | |
| 10:20 AM - 10:35 AM | Break | |
| 10:35 AM - 11:15 AM | Management of Glucose, Temperature, and Ventilation Jose I. Suarez, MD, FAAN | |
| 11:15 AM - 12:00 PM | Role of Recombinant Factor VIIa Michael D. Hill, MD | |
| 12:00 PM - 12:45 PM | Discussion | 
| Michael N. Diringer, MD | No disclosure on file | 
| Michael D. Hill, MD | Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular. | 
| Venkatesh Aiyagari, MD | Dr. Aiyagari has received publishing royalties from a publication relating to health care. | 
| Jose I. Suarez, MD, FAAN | Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Mayo Clinic. |